MSH2 and neoplasm: dMMR results from genetic inactivation of MLH1, MSH2, MSH6, PMS2 or methylation of MLH1. These tumours are characterized by a hypermutator-phenotype leading to high mutation loads and a large fraction of small insertions and deletions (indels), predominantly in homopolymer and dinucleotide repeats.